Selpercatinib - Loxo oncology
At a glance
- Drug Originator Array BioPharma
- Drug Licenced by Innovent Biologics; Loxo Oncology
- Drug Class Antineoplastics; Aza compounds; Ethers; Nitriles; Pyrazoles; Pyridines; Small molecules
- Mechanism of Action Proto-oncogene protein c-ret inhibitors; Type 1 fibroblast growth factor receptor antagonists; Type 3 fibroblast growth factor receptor antagonists; Type-2 fibroblast growth factor receptor antagonists; Vascular endothelial growth factor receptor-1 antagonists; Vascular endothelial growth factor receptor-3 antagonists
- USA Patent Applicants ELI LILLY AND CO
- USA Patents 18
- NDAs 2
- International Patents 138
- Patent Applications 51
Disclaimer